Navigation Links
Urocidin™ Phase III Clinical Trial Results Presented at AUA Conference in Washington, D.C.
Date:5/17/2011

CHADDS FORD, Pa. and BELLEVILLE, Ontario, May 17, 2011 /PRNewswire/ -- Endo Pharmaceuticals and Bioniche Life Sciences today presented Phase III trial results for the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™, during a podium presentation at the 2011 American Urological Association annual meeting in Washington, D.C. The preliminary results from the interim analysis of this prospective trial indicate that Urocidin™ may provide an alternative to cystectomy for patients with bacillus Calmette-Guerin (BCG) refractory non-muscle invasive bladder cancer (NMIBC).

The preliminary results were generated from an interim analysis in an ongoing Phase III trial with Urocidin™ in the treatment of NMIBC that is refractory to BCG and at high risk of progression.

The Results

A total of 129 patients were enrolled from 25 centers in the U.S. and Canada, with high grade papillary tumors and/or carcinoma in situ (CIS) and having failed to respond to one or more courses of BCG. According to the preliminary results the overall one-year disease-free survival (DFS) rate was 25 percent. DFS is defined as lack of recurrence or progression to muscle-invasive disease, as confirmed by biopsy. The one-year DFS rate was 35 percent for patients with only papillary tumors and 21 percent for patients with carcinoma in situ (CIS) with or without papillary tumors. The preliminary results indicate that intravesical administration of Urocidin™ was well tolerated.

Ongoing Phase III Clinical Program with Urocidin™

Summary details of a Phase III clinical trial protocol with Urocidin™ being conducted by Endo are publicly available via the U.S. National Institutes of Health (NIH) clinical trial registration service at http://www.clinicaltrials.gov. This trial is active
'/>"/>

SOURCE Endo Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
2. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
3. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
4. Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
5. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
6. Independent Investigator Initiates Phase 1 Study of Biodels Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
7. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
8. Intravenous (IV) Administration of Cempra Pharmaceuticals Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial
9. Selexys Pharmaceuticals Initiates Enrollment in Phase I Clinical Study of SelG1
10. SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Building on the momentum of the first quarter of ... alert systems, has announced aggressive plans to expand its Medicaid ... Care business models. The first quarter addition of ... Tennessee and Louisiana is ... span statewide coverage in each state. This brings the total ...
(Date:3/30/2015)... 26, 2015 Research and Markets ... addition of the "Urological Catheters - ... their offering. This report analyzes ... Thousand Units and US$ Thousands by the ... & Peritoneal Catheters), and Urinary Catheters (Foley ...
(Date:3/30/2015)... , March 30, 2015  Rigrodsky & Long, P.A.: ... Inc. (NASDAQ GM: ASPX )? , Did you ... , Do you think the proposed buyout price is ... rights? Rigrodsky & Long, P.A. ... board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" or the ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
(Date:3/30/2015)... The fertility team at Ada IVF ... questions to give intended parents across the globe a ... , After unveiling the most affordable, non-sharing ... clinic has witnessed an increase in fertility patients. Led ... attentive reproductive care — with all-inclusive IVF treatment options ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 “ iCareTech ” ... Report, which takes a look at the latest and coolest ... NewsWatch special reporter and technology expert, conducted the review and ... band that’s dedicated to the medical and health fields. , ... of conversation over the past couple of years. Well, at ...
(Date:3/30/2015)... 2015 Healthy, radiant skin can be ... staff of pharmacists is specially trained and skilled in ... eczema and other conditions. , Most people are unaware ... and/or PCP to tackle most skin conditions and offer ... employed specialty-trained pharmacists who have experience in consulting with ...
(Date:3/30/2015)... A key protein previously implicated in ... important role in the response to viral infection, according ... School of Medicine at Mount Sinai published today in ... associated with inflammation, part of the body’s response to ... in to attack invaders like bacteria and viruses, and ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
Breaking Medicine News(10 mins):Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3
... in Desso ... Turf, BRUSSELS, Belgium, ... in a few synthetic turf,fields. The fields in question are not manufactured by ... assured that,their pitch doesn,t contain any lead., All Desso synthetic turf products ...
... Eating out is common while traveling, but it,s important to ... Memorial Day marks the start of the summer holiday season, ... take a vacation from your diet, cautions Elizabeth Schaub, a ... , Dining out is common when people are on holidays, ...
... tool for mopping up the clumps of mutant protein ... engineered a virus to make an intracellular antibody or ... the brain cells of people with Huntington,s. , Injecting ... mutant huntingtin improves their ability to move their limbs, ...
... in 2007but the price of phosphate fertilizers then doubled ... months from February through April 2008. The effects on ... in Sichuan Province, Chinaa major production area for nitrogen ... had already imposed dramatic new export duties on fertilizer, ...
... and a mathematician may seem like an unlikely duo, but ... and kept millions of sailors from getting lost at sea. ... Rockefeller University, is making history of their own. By using ... have become the first to see, in real time and ...
... sun-related vision damage without proper protection , , SUNDAY, May ... you,re thinking about ultraviolet (UV) protection as the weather ... the sun,s UV rays has been linked to a ... photokeratitis and corneal degenerative changes, according to the American ...
Cached Medicine News:Health News:It's Safe to Play on Desso Synthetic Turf 2Health News:It's Safe to Play on Desso Synthetic Turf 3Health News:Don't Leave Diet Out to Lunch on Vacation 2Health News:'Intrabody' can mop up mutant protein in Huntington's disease model 2Health News:World fertilizer prices continue to soar, scientists stress need for fertilizer efficiency 2Health News:World fertilizer prices continue to soar, scientists stress need for fertilizer efficiency 3Health News:Scientists image a single HIV particle being born 2Health News:Scientists image a single HIV particle being born 3Health News:Just Like Skin, Eyes Can 'Burn' in Strong Sun 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: